H-group (homology)
1.1 RIFT-related
Ligands and drugs
74,430
Member domains
14,755
with ligand contacts (≤ 4 Å)
19.8% of members
14,669
with DrugDomain annotations
19.7% of members
8,168
with a DrugBank compound
11.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1.1 belongs to X-group 1 cradle loop barrel, which binds 9.4 ligand superclasses per 20 proteins, broader than 87% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | FLAVIN-ADENINE DINUCLEOTIDE | 463 |
| DB00141 | NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 369 |
| DB00114 | PLP | PYRIDOXAL-5'-PHOSPHATE | 173 |
| DB03247 | FMN | FLAVIN MONONUCLEOTIDE | 162 |
| DB01264 | 017 | (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE | 161 |
| DB02078 | PG5 | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE | 98 |
| DB03461 | NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 96 |
| DB00171 | ATP | ADENOSINE-5'-TRIPHOSPHATE | 71 |
| DB01232 | ROC | (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide | 65 |
| DB09459 | TLA | L(+)-TARTARIC ACID | 62 |
| DB03345 | BME | BETA-MERCAPTOETHANOL | 59 |
| DB00701 | 478 | {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER | 54 |
| DB16833 | ADP | ADENOSINE-5'-DIPHOSPHATE | 43 |
| DB00224 | MK1 | N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARYBUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE | 36 |
| DB06841 | 0G6 | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | 35 |
| DB00503 | RIT | RITONAVIR | 33 |
| DB02313 | AG7 | 4-{2-(4-FLUORO-BENZYL)-6-METHYL-5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-4-OXO-HEPTANOYLAMINO}-5-(2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER | 32 |
| DB03913 | F42 | COENZYME F420 | 31 |
| DB18834 | 7YY | 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione | 31 |
| DB01694 | TAR | D(-)-TARTARIC ACID | 29 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 2,171 |
| CL | CHLORIDE ION | 1,176 |
| CAmetal | CALCIUM ION | 1,114 |
| NAmetal | SODIUM ION | 628 |
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 459 |
| ZNmetal | ZINC ION | 429 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 335 |
| MNmetal | MANGANESE (II) ION | 237 |
| Kmetal | POTASSIUM ION | 183 |
| IOD | IODIDE ION | 174 |
| MGD | 2-AMINO-5,6-DIMERCAPTO-7-METHYL-3,7,8A,9-TETRAHYDRO-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-4-ONE GUANOSINE DINUCLEOTIDE | 162 |
| 017 | (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE | 161 |
| FMN | FLAVIN MONONUCLEOTIDE | 156 |
| PLP | PYRIDOXAL-5'-PHOSPHATE | 145 |
| BEN | BENZAMIDINE | 144 |
| OHX | osmium (III) hexammine | 130 |
| PG5 | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE | 98 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 91 |
| U1H | [4-(trifluoromethyl)phenyl]methanamine | 78 |
| UNX | UNKNOWN ATOM OR ION | 77 |